Mold: The Black Hole of Conventional Medicine?

Mycotoxins — the chemical "weapons" of mold — can, in experiments, be stored in fat tissue, organs, and the nervous system, where they may act in neurotoxic, immunotoxic, hepatotoxic, nephrotoxic, endocrine-active, and in some cases carcinogenic ways. More than 100 different mycotoxins have been described — research has by now reached over 400 variants.

And: mold does not have to be visible. It can sit inside walls behind wallpaper, in mattresses, in air-conditioning systems, in basements, and in water-damaged building materials. The visible patch is not the biggest problem — the bigger issue is the invisible spores and toxins you breathe in every day.

Several mycotoxins can act in a neurotoxic way in laboratory models. Ochratoxin A (OTA) crosses the blood-brain barrier, induces neuronal apoptosis, and has been linked to Alzheimer-like pathomechanisms. 🔬 In vitro T-2 toxin in animal models causes oxidative stress, mitochondrial damage, and neuroinflammation — measurable in the behavior of animals that suddenly become disoriented, more anxious, and cognitively slower. 🐭 In vivo Deoxynivalenol (DON) has been shown to impair learning and memory and to trigger aversive emotions via specific brain circuits. 🐭 In vivo

What this can mean in everyday life: imagine you try to finish a thought — but in the middle of the sentence it is gone. You know you were just thinking about something, but what was it? You enter your PIN and three seconds later cannot remember whether you typed it correctly. You read the same paragraph three times and it makes no sense. Many people call this "brain fog" — and to outsiders it sounds like poor concentration or laziness. For those affected, it is real fog.

On top of this comes overstimulation: sounds that used to be normal now feel unbearably loud. A supermarket becomes torture. A conversation in a noisy group is, after twenty minutes, exhausting like a marathon. These are not psychological sensitivities — they could be signs of a nervous system stuck permanently in alarm mode. 🏥 Clinical

From a PNI (psychoneuroimmunology) perspective: the immune system is irritated by mycotoxins → it releases pro-inflammatory cytokines → these messengers cross the blood-brain barrier → they activate microglia (the brain's immune cells) → the brain enters a "sickness behavior" mode: slower thinking, social withdrawal, low mood, little energy. This is a protective response from the body — not a character flaw, not weakness.

Where these people end up: in psychiatry (diagnosis: depression, anxiety disorder, adjustment disorder), at the neurologist (MRI unremarkable, nerve conduction velocity normal, work-up for MS or dementia — all without clear findings). The MRIs are unremarkable. Nerve conduction velocity is fine. Bloodwork shows nothing spectacular. And yet daily life feels as if the nervous system is permanently in emergency mode.

A note on the evidence: 👤 Human For human studies on brain fog and cognitive impairment after mold exposure, there are limited, mostly uncontrolled observational studies without control groups. RCTs do not exist — they are not ethically feasible. The AWMF guideline classifies neurotoxic effects from indoor mold as "insufficiently proven." The mechanisms are biologically highly plausible — the causal human proof is still missing. That does not mean the suffering is not real.

Mycotoxins show a bidirectional immune effect — depending on dose and duration, they can drive the immune system in two opposite directions, which explains the diagnostic confusion. At low doses, many mycotoxins activate inflammatory responses (NF-κB pathway) — the immune system "fires." At high doses or with long exposure, they suppress it — the immune system becomes exhausted. 🔬 In vitro🐭 In vivo

The clinical picture: those affected by a suppressed immune system get constant minor infections, can no longer shake off colds, feel "permanently slightly ill." Those stuck in over-arousal mode react to everything: new allergies appear, intolerances pile up, skin reactions come and go. Sometimes the two phases alternate — which makes diagnosis nearly impossible.

A note on the evidence: 👤 Human For autoimmune diseases as a direct consequence of indoor mold exposure, there are no controlled human studies. For the EBV link, an experimental mechanistic proof exists in a cell model. The AWMF guideline classifies autoimmune diseases due to mold as "insufficiently proven." But the clinical pattern remains striking — and silence in research does not mean the opposite has been proven.

Mitochondria are the energy factories of your cells. They convert glucose and oxygen into ATP — the body's universal energy carrier. Every muscle movement, every thought, every heartbeat, every breath needs ATP. When mitochondria function poorly, the whole system lacks energy — not in one place, but everywhere at once.

Practically all mycotoxins that have been studied damage mitochondria via the same convergent mechanism: ROS overproduction → collapse of the mitochondrial membrane potential → cytochrome C release → cell death. 🔬 In vitro Ochratoxin A, T-2 toxin, DON, and zearalenone all show this pathway in cell cultures. OTA specifically damages kidney cells via ferroptosis (Zhou et al. 2025). T-2 toxin attacks the mitochondria in nerve cells through the NRF2/PGC-1α pathway (Pang et al. 2022).

Picture mitochondria as batteries: under normal stress they can recharge. But when mycotoxins constantly generate ROS (free radicals), the battery is in permanent discharge mode. The body tries to neutralize the free radicals with antioxidants — above all with glutathione, the body's strongest protective compound. And then this happens: the glutathione reserves drain faster than they can be replenished. 🔬 In vitro

This explains an observation I make very frequently in clinical practice: 🏥 Clinical when I give people with possible mold burden glutathione infusions — which should actually be very supportive — some react paradoxically: briefly better, then worse, or even an immediate reaction. This happens because the mobilized glutathione suddenly drives mycotoxin elimination — and if the elimination pathways (gut, liver, kidneys) are not ready, the body is overwhelmed by the toxic load. This is not a sign that glutathione is bad. It is a sign that the order of operations matters.

What this means in everyday life: you wake up in the morning and are already exhausted — even after 9 hours of sleep. You drop the kid off at school and afterward you're done for the day. A short shopping trip feels like an ultramarathon. You have "lead in your muscles." Your brain runs on fumes. And the alarming part: on good days you think it is going uphill — and then a crash comes that knocks you back for days. This is not a failure of willpower; it is cell biology.

Connection to ME/CFS: 👤 Human An uncontrolled study (Wu et al. 2022, n=236 ME/CFS patients) found mycotoxins in the urine of 92.4% — without a control group. That is methodologically weak, but clinically very striking. For fibromyalgia, there are no studies. The mechanisms (mitochondrial damage, oxidative stress, glutathione depletion) are biologically highly plausible as contributing factors to both clinical pictures.

Here is an honest presentation of the facts — because I think it is important not to create false fear, but also not to downplay real risks.

What is established: 👤 Human Aflatoxin B1 (AFB1) is classified by the IARC as Group 1 — "established human carcinogen." The mechanism is precisely worked out: AFB1 is converted in the liver into a highly reactive epoxide → binds to DNA → produces a specific mutation in the TP53 tumor suppressor gene (R249S mutation) → increased risk of hepatocellular carcinoma. Particularly critical is the combination with hepatitis B infection: the joint risk is multiplicative, not additive. AFB1 is found mainly in foods (nuts, corn, grains in warm climates) — for indoor mold in Central Europe, AFB1 is rarely the main culprit.

What is likely problematic but not established in humans: 🐭 In vivo Ochratoxin A (IARC Group 2B) and fumonisin B1 cause tumors in animal experiments. For humans, the evidence is not sufficient for Group 2A or Group 1. Zearalenone, DON, and T-2 toxin are IARC Group 3 — "not classifiable as to carcinogenicity." That means: the data is sufficient neither for nor against a classification. It does not mean they are harmless.

What concerns me clinically is not the individual risk of a single mycotoxin — but the toxic cocktail effect: when mycotoxins combine with other environmental toxins (solvents, pesticides, heavy metals), chronic inflammation, and nutrient deficiencies, the sum of the burden on cell division, DNA repair, and detoxification capacity could be relevant — even if no single factor alone clearly raises the risk. This is not an alarm scenario. But it is a reason to take unnecessary chronic exposures seriously.

What this means: we are not talking about a patch of mold causing cancer. We are talking about years of exposure combined with weakened detoxification, nutrient deficiencies, and chronic inflammation — as one of many possible factors in a complex picture.

Zearalenone (ZEN) is one of the most potent known mycoestrogens — so-called xenoestrogens, that is, foreign substances that act like estrogen but are not estrogen. Its structure is so similar to that of natural estrogens that it can bind competitively to estrogen receptors (ERα and ERβ). The metabolite α-zearalenol shows even three times higher estrogenic potency than ZEN itself. 🔬 In vitro

What this can mean in the body: tissue "reads" an estrogen message — but not from real estrogen, rather from a foreign substance occupying the receptors. The lab measures normal. The body, however, behaves as if there were estrogen dominance. And no standard lab would find ZEN in the blood — because no one is looking for it.

In rat models, ZEN induced PCOS-like states with hyperovulation, cysts, and elevated testosterone (Alenazi et al. 2024 🐭 In vivo). ZEN has been detected in human endometrial tissue — clinical relevance for human reproduction is biologically plausible, but not established in controlled human studies.

Typical patterns with zearalenone exposure: cycle disturbances, worsened PMS, heavier bleeding, breast tenderness, weight gain in classic "estrogen areas," fibroid-like complaints, endometriosis-like pain, infertility without an explainable cause. The treacherous part: standard hormonal lab work is completely unremarkable. The tissue "experiences" estrogen action — the lab does not see it, because ZEN is not estrogen.

A note on the evidence: 👤 Human For the link with human cycle disturbances, PMS, or endometriosis, no controlled intervention studies exist. The estrogen-like mechanism is well documented in vitro and in vivo (animal). The clinical relevance in humans remains scientifically uncertain — but clinically striking enough to actively ask about it in cases of unclear hormonal complaints with a mold history.

The gut is not just a digestive organ — with about 70% of immune cells, it is one of the largest immune organs in the body. It is also the first barrier mycotoxins must pass when ingested orally. Which means: when you live in a moldy house, you breathe in and swallow spores and toxins — and the first stop for many of these substances is the intestinal lining.

DON (deoxynivalenol) is considered a marker substance for damage to the gut barrier. In cell and animal models, DON destroys the tight-junction proteins occludin, claudin-1, and ZO-1 — the molecular "rivets" that hold intestinal epithelial cells together. 🔬 In vitro🐭 In vivo When these connections loosen, what is colloquially called "leaky gut" arises — increased permeability that lets bacterial components, undigested food particles, and toxins into the bloodstream. The immune system enters constant alarm.

Particularly compelling: Fan et al. (2024) showed in an animal experiment that DON-damaged gut bacteria, when transferred to healthy mice, reproduced the same gut problems — a causal demonstration of the harmfulness of the altered microbiome itself. 🐭 In vivo The interaction is bidirectional: mycotoxins alter the microbiome, and the altered microbiome makes the mycotoxin burden worse.

What I see again and again clinically: 🏥 Clinical

• Paradoxical reactions: probiotics, which should actually help, trigger bloating, pain, or worsening. This is not a sign that probiotics are bad — it could be a sign that the microbiome is so destabilized that even good bacteria trigger a dysregulated immune system.
• Stool as a barometer: bowel movements after which skin, mucous membranes, or general well-being suddenly worsen. That fits with intestinal mucosa coming into contact with toxins at every emptying.
• Food intolerances that suddenly appear: foods that used to be fine now trigger problems. Often this is not a real immune problem with the food — it is a problem of barrier integrity. When the gut wall is leaky, proteins are absorbed that would normally never enter the bloodstream.

Elimination also runs through the gut: stool is one of the most important elimination routes for mycotoxins. If someone is chronically constipated, mycotoxins excreted into the gut with bile are reabsorbed there — a toxic cycle. Regular, well-formed stool is therefore not just about comfort — it is a therapeutic foundation.

A note on the evidence: 👤 Human No randomized controlled human studies on the effect of indoor mycotoxins on the human gut barrier. DON is ubiquitously detectable in human body fluids from food sources. Whether indoor concentrations cause clinically meaningful barrier disturbances is not proven — but the mechanistic animal models are clear.

The skin and mucous membranes are literally the interface between the inner and outer world. They are barrier organs — and when the inner barriers (gut, lungs) are under pressure, that often shows up first at the outermost interface: the skin.

What I keep noticing clinically: 🏥 Clinical

• Itchy, shifting rashes: not in a fixed spot, but wandering. Today the forearms, next week the ankles, then suddenly the back. The wandering confuses dermatologists — and that is exactly what is striking.
• Eczema-like areas without a classic atopic pattern: no family history, no typical childhood eczema — but suddenly appearing inflamed areas. Often they correlate with bowel movements or with time spent in certain rooms.
• Burning, red eyes: especially after waking up (after a night in a possibly affected bedroom), after coming home from the office. Dry, irritated conjunctiva without signs of infection.
• Chronic sinusitis: repeatedly congested sinuses, mucus production that won't go away. What if the nasopharynx is in direct contact with a mold reservoir in the air conditioning or the walls?

The skin is the first organ to show when the immune system, barriers, and detoxification reach their limits. That makes biological sense: the body tries to clear excess toxins and inflammatory products via the skin as well. What looks like a skin problem is sometimes a detoxification problem.

What is well documented here: 👤 Human For allergic respiratory diseases, asthma, and allergic rhinitis caused by indoor mold, there are meta-analyses with thousands of participants — this is the most robustly documented part of the mold-health connection. The WHO (2009) estimates that ~21% of current asthma may be attributable to indoor dampness and mold. Jaakkola et al. (2013, n = several thousand) found an OR of 1.82 for allergic rhinitis with visible mold. That is solid human evidence.

For the other skin manifestations — wandering eczema, inflammatory rashes — there are no controlled human studies on mold exposure. The clinical pattern, however, is consistently described in environmental medicine.

What keeps coming up — and almost always leaves cardiologists puzzled: 🏥 Clinical

• Palpitations without findings: palpitations that suddenly appear — when standing up, after eating, sometimes at night. ECG unremarkable, Holter monitor only shows "sinus tachycardia under stress." But why does someone have permanent "stress" in their heart, even on vacation?
• Dizziness when standing up: what conventional medicine describes as "orthostatic dysregulation" or mild POTS-type symptoms. Blood pools downward when standing up, the heart has to pump harder, the head briefly receives too little circulation. In some people affected by mold, this could be linked to autonomic dysregulation — the autonomic nervous system, due to chronic strain, is impaired in its regulatory capacity.
• Temperature chaos: alternating between freezing and hot flashes. Cold in the morning, hot in the afternoon, cold again in the evening. That fits an autonomic nervous system that can no longer keep thermoregulation stable — because it is overloaded by other regulatory loops.
• Daytime crashes: you have a good hour and think today will be a productive day. Then comes the crash — suddenly all energy is gone, the head heavy, muscles powerless. As if someone flipped a switch. This is not imagination; it is a metabolic collapse at the cellular level.

From a PNI perspective, this forms a coherent picture: the autonomic nervous system — sympathetic (gas) and parasympathetic (brake) — is the body's conducting system. When mycotoxins irritate the immune system, weaken the mitochondria, and put the nervous system in constant alarm, the autonomic nervous system loses its flexibility. It can no longer switch quickly between activity and recovery. This is called low heart rate variability (HRV) — and that is exactly what I measure in many people affected by mold when I run an HRV analysis. 🏥 Clinical

The result feels like: "My body is constantly at 130% — without me doing anything big." Not because you are weak. But because your system is fighting on several levels at once and can no longer find a real recovery mode.

A note on the evidence: for autonomic dysregulation due to mycotoxins, no direct human studies exist. The mechanism via neuroinflammation → autonomic dysregulation is biologically well grounded, but in humans it has not been specifically demonstrated for mold exposure.